Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

277
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
277
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

873
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
873
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

273
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
273
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary Hypertension.

Clinical transplantation·2026
Same author

Use of Rifampicin as a Cytochrome Inducer in Acute Tacrolimus Poisoning.

Open respiratory archives·2026
Same author

An Unusual Cause of Pulmonary Nodules.

Open respiratory archives·2026
Same author

SEPAR Recommendations on Vaccination for Chronic Respiratory Patients.

Archivos de bronconeumologia·2025
Same author

Pulmonary Calcifications: A Reflection of Renal Impairment.

Open respiratory archives·2025
Same author

[Current Status of Passive Immunization Against COVID in Respiratory Patients].

Open respiratory archives·2025

Related Experiment Video

Updated: Jul 21, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K

[Interstitial Lung Disease].

Juan Margallo Iribarnegaray1, María Churruca Arróspide2, Cristina Matesanz López3

  • 1Servicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, España.

Open Respiratory Archives
|July 27, 2023
PubMed
Summary

Interstitial lung diseases (ILD) are complex respiratory conditions. Recent advances have improved understanding of their causes, diagnosis, and treatments, offering new hope for patients.

Keywords:
Antifibrotic therapyIdiopathic pulmonary fibrosisInterstitial lung diseaseInterstitial pneumonia with autoinmune featuresProgressive pulmonary fibrosis

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

929
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.3K

Related Experiment Videos

Last Updated: Jul 21, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

929
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.3K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Pathophysiology

Context:

  • Diffuse interstitial lung diseases (ILD) represent a diverse group of respiratory disorders.
  • These conditions share common clinical, radiological, physiological, and pathological features.
  • Recent scientific breakthroughs have significantly advanced ILD research.

Purpose:

  • To provide a question-and-answer overview of interstitial lung diseases.
  • To highlight key advancements in ILD pathophysiology.
  • To detail recent changes in ILD diagnosis and treatment.

Summary:

  • Significant progress in understanding ILD pathophysiology has been made.
  • New treatments have emerged, transforming disease management.
  • This Q&A format addresses critical updates in the field.

Impact:

  • Enhanced understanding of ILD mechanisms.
  • Introduction of paradigm-shifting treatments for ILD.
  • Improved diagnostic and therapeutic strategies for respiratory specialists.